ES8305003A1 - "procedimiento para la preparacion de derivados de androstano". - Google Patents

"procedimiento para la preparacion de derivados de androstano".

Info

Publication number
ES8305003A1
ES8305003A1 ES514492A ES514492A ES8305003A1 ES 8305003 A1 ES8305003 A1 ES 8305003A1 ES 514492 A ES514492 A ES 514492A ES 514492 A ES514492 A ES 514492A ES 8305003 A1 ES8305003 A1 ES 8305003A1
Authority
ES
Spain
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
androstane derivatives
image
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES514492A
Other languages
English (en)
Other versions
ES514492A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of ES8305003A1 publication Critical patent/ES8305003A1/es
Publication of ES514492A0 publication Critical patent/ES514492A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/006—Ketals at position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • C07J53/005—3 membered carbocyclic rings in position 12
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • C07J53/008—3 membered carbocyclic rings in position 15/16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE DERIVADOS DE ANDROSTANO, DE FORMULA (I), EN LA QUE LA LINEA DISCONTINUA SIGNIFICA UN POSIBLE ENLACE; R ES METILO O ETILO; R ES HIDROGENO O ALCOHILO C <- ; Y X, -A-B-, -U-V- Y -W-Y- PUEDEN SER VARIOS TIPOS DE GRUPOS O RADICALES. CONSISTE EN LA REACCION DE ESTERIFICACION DEL DERIVADO DE ANDROSTANO DE FORMULA (II), CON UN ACIDO DE FORMULA R COOH, O UN DERIVADO REACTIVO DEL MISMO, FORMULAS EN LAS QUE TODOS LOS SIMBOLOS TIENEN EL MISMO SIGNIFICADO QUE EN LA FORMULA (I). LA REACCION SE LLEVA A CABO EN PRESENCIA DE CATALIZADORES DE ESTERIFICACION O, EN SU CASO, EN PRESENCIA DE BASES. ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS PARA EL TRATAMIENTO TOPICO DE ENFERMEDADES TALES COMO ACNE Y SEBORREA.
ES514492A 1981-07-29 1982-07-29 "procedimiento para la preparacion de derivados de androstano". Granted ES514492A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19813130644 DE3130644A1 (de) 1981-07-29 1981-07-29 Neue androstan-derivate, verfahren zu ihrer herstellung und pharmazeutische praeparate, die diese verbindungen enthalten

Publications (2)

Publication Number Publication Date
ES8305003A1 true ES8305003A1 (es) 1983-04-16
ES514492A0 ES514492A0 (es) 1983-04-16

Family

ID=6138450

Family Applications (1)

Application Number Title Priority Date Filing Date
ES514492A Granted ES514492A0 (es) 1981-07-29 1982-07-29 "procedimiento para la preparacion de derivados de androstano".

Country Status (17)

Country Link
US (2) US4457925A (es)
EP (1) EP0071153B1 (es)
JP (1) JPS5849400A (es)
AT (1) ATE22086T1 (es)
AU (1) AU558412B2 (es)
CA (1) CA1210754A (es)
DE (2) DE3130644A1 (es)
DK (1) DK164325B (es)
ES (1) ES514492A0 (es)
FI (1) FI78110C (es)
GB (1) GB2104899B (es)
GR (1) GR76872B (es)
IE (1) IE53711B1 (es)
IL (1) IL66311A (es)
NO (1) NO159661C (es)
PT (1) PT75334B (es)
ZA (1) ZA825480B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3331824A1 (de) * 1983-09-01 1985-03-21 Schering AG, Berlin und Bergkamen, 1000 Berlin Verfahren zur herstellung von 17(alpha)-acyloxy-6-chlor-1(alpha),2(alpha)-methylen-3,20-dionen
DE3347126A1 (de) * 1983-12-22 1985-07-11 Schering AG, 1000 Berlin und 4709 Bergkamen 11ss-aryl-estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate
US4720489A (en) * 1984-10-15 1988-01-19 Douglas Shander Hair growth modification with ornithine decarboxylase inhibitors
JPS61286185A (ja) * 1985-06-13 1986-12-16 Yoshizo Koishi 刻印装置
DE3824247A1 (de) * 1988-07-13 1990-01-18 Schering Ag Neue androstan-derivate
GB9021546D0 (en) * 1990-10-04 1990-11-21 Beecham Group Plc Novel composition
DE4102244A1 (de) * 1991-01-24 1992-07-30 Schering Ag 14,16ss-ethano-15ss, 16(pfeil hoch)1(pfeil hoch)-cyclo-14ss-estra-1,3,5(10)-triene
US5411991A (en) * 1992-12-22 1995-05-02 Shander; Douglas Method of reducing hair growth employing sulfhydryl active compounds
US6743419B1 (en) 1992-12-22 2004-06-01 The Gillette Company Method of reducing hair growth employing sulfhydryl active compounds
EP1615944A4 (en) * 2003-04-01 2010-08-11 Harbor Biosciences Inc ANTI-ORANGE PROBLEMS WITH MARGINAL AGONIST EFFECT AND METHOD OF USE
US8084446B2 (en) * 2005-04-26 2011-12-27 Eric Marchewitz Use of DHEA derivatives for enhancing physical performance
US20130123523A1 (en) * 2011-11-10 2013-05-16 Klaus Nickisch Methods for the preparation of etonogestrel and desogestrel

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR7871M (es) * 1968-11-13 1970-04-27
IE44711B1 (en) * 1976-03-05 1982-03-10 Schering Ag 17 -hydroxypropyl-4-3-keto-steroids and esters thereof, and process for their manufacture
DE2644427A1 (de) * 1976-09-30 1978-04-06 Schering Ag 17 beta-hydroxy-17 alpha-(3-acyloxypropyl)-4.6-androstadien-3-one und deren salze
DE2722706A1 (de) * 1977-05-16 1978-12-07 Schering Ag 15.16-methylen-androsta-4.15-dien- 3-one und verfahren zu ihrer herstellung
ES469510A1 (es) * 1977-05-16 1978-12-01 Schering Ag Procedimiento para la preparacion de 17beta hidroxi-4-an- drosten-3-onas.

Also Published As

Publication number Publication date
GB2104899A (en) 1983-03-16
FI78110B (fi) 1989-02-28
PT75334A (de) 1982-08-01
IE821824L (en) 1983-01-29
DK327082A (da) 1983-01-30
ATE22086T1 (de) 1986-09-15
AU558412B2 (en) 1987-01-29
NO822596L (no) 1983-01-31
JPH033678B2 (es) 1991-01-21
FI822658A0 (fi) 1982-07-29
FI78110C (fi) 1989-06-12
ES514492A0 (es) 1983-04-16
EP0071153A1 (de) 1983-02-09
DK164325B (da) 1992-06-09
PT75334B (de) 1984-07-31
DE3273186D1 (en) 1986-10-16
ZA825480B (en) 1983-11-30
IL66311A0 (en) 1982-11-30
US4587235A (en) 1986-05-06
NO159661C (no) 1989-01-25
IE53711B1 (en) 1989-01-18
IL66311A (en) 1986-03-31
DE3130644A1 (de) 1983-02-17
US4457925A (en) 1984-07-03
EP0071153B1 (de) 1986-09-10
FI822658L (fi) 1983-01-30
GB2104899B (en) 1985-01-30
CA1210754A (en) 1986-09-02
GR76872B (es) 1984-09-04
AU8643982A (en) 1984-10-18
NO159661B (no) 1988-10-17
JPS5849400A (ja) 1983-03-23

Similar Documents

Publication Publication Date Title
DE3367774D1 (de) 5,6,7-trinor-4, 8-inter-m-phenylene prostaglandin i2 derivatives
ES8305003A1 (es) &#34;procedimiento para la preparacion de derivados de androstano&#34;.
GB1536515A (en) Compositions containing silicon derivatives
ES8505518A1 (es) Procedimiento para preparar derivados de aminoacidos
DE3266845D1 (en) Hydrocortisone derivatives, their preparation and their utilization
ZA836090B (en) Thieno-thiazole derivatives,processes for preparing these compounds,and pharmaceutical compositions thereof
ES432288A1 (es) Procedimiento para preparar derivados de ergopectina.
IL63747A0 (en) New cardenolide bis-digitoxosides,processes for the preparation thereof and pharmaceutical compositions containing them
US4264523A (en) 19,20-Didehydro-13,14-dihydro-PG1 amides
ES8300675A1 (es) Procedimiento de preparacion de derivados de etanolamina.
US4257982A (en) 2-Decarboxy-2-aminomethyl-19,20-didehydro-13,14-dihydro-PG2 compounds
US4278813A (en) 19,20-Didehydro-13,14-dihydro-PG2, sulfonyl amides
ES484712A1 (es) Un procedimiento para la preparacion de 3b-amino-2b-hidroxi (aciloxi) esteroides.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970519